HCV: hepatitis C virus
Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
10
Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification.: m2000SP/m2000RT FOR HCV RNA QUANTIFICATION
28
New pandemics: HIV and AIDS, HCV and chronic hepatitis, Influenza virus and flu
9
Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo.: HCV protein expression in intestine
25
Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients?
2
Reconstitution of the entire hepatitis C virus life cycle in non-hepatic cells.: HCV life cycle in non-hepatic cells
30
Host cell responses induced by hepatitis C virus binding.: Host cell responses induced by HCV
4
Correlates of Long-term Immune Protection in Hepatitis C Virus (HCV) Exposed Non-reinfected Individuals
138
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma
14
Chronic hepatitis C virus infection, a new cardiovascular risk factor?
20
Evidence that hepatitis C virus genome partly controls infection outcome
16
Host–virus interactions during hepatitis C virus infection : a complex and dynamic molecular biosystem
13
Liver stiffness diminishes with antiviral response in chronic hepatitis C.: Liver Stiffness Kinetics on HCV Therapy
29
Development of hepatitis C virus vaccines: challenges and progress.
36
Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis
4
Hepatitis C virus entry.
42
Relationship between humoral response against hepatitis C virus and disease overcome
13
Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.
17
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.
25
Hepatitis C Virus Infection, a New Modifiable Cardiovascular Risk Factor
16